BiotechTube
Exeltis Turkey

Exeltis Turkey

Istanbul, Europe - Other· Est.
exeltis.com.tr
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $30M

Overview

Exeltis Turkey, established in 2003, is a key commercial and manufacturing arm of the Insud Pharma group in the Turkish pharmaceutical market. As a generics-focused company, it aims to increase access to essential medicines through local production and distribution. Its strategic position in Istanbul allows it to serve as a regional hub. The company's success is tied to Turkey's healthcare policies, generic penetration rates, and its ability to navigate the competitive local landscape.

Women's HealthCentral Nervous SystemCardiovascularAnti-infectives

Technology Platform

Generic drug development and manufacturing, focusing on formulation science, bioequivalence studies, and analytical testing.

Funding History

1
Total raised:$30M
Series A$30M

Opportunities

Growth driven by Turkish government policies promoting generic drug usage and local manufacturing.
Potential to act as a regional hub for the Insud Pharma group, expanding reach into neighboring markets.

Risk Factors

Faces significant regulatory pricing pressure and intense competition in the crowded Turkish generics market.
Macroeconomic instability and currency volatility in Turkey pose operational and financial risks.

Competitive Landscape

Operates in a highly competitive Turkish generics market with numerous domestic firms (e.g., Abdi İbrahim, Nobel İlaç) and multinational generics companies. Competition is primarily based on price, regulatory execution speed, and distribution network strength.

More companies in Europe - Other →